Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sepsis Set Back: AstraZeneca CytoFab Development Will Be Delayed Two Years
Nov 03 2006
•
By
Jessica Merrill
More from Archive
More from Pink Sheet